| Financial Year |
March 31 2023 |
| Monetary Funds |
735,245,945.06 |
| Held-for-trading Financial Assets |
960,151,027.31 |
| Notes Receivable |
11,554,010.53 |
| Accounts Receivable |
479,773,318.38 |
| Advances to Suppliers |
49,542,970.33 |
| Other Receivables |
55,523,626.68 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
8,388,500.00 |
| Inventories |
284,069,034.73 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,556,349,399.08 |
| Other Current Assets |
292,785,498.51 |
| Total Current Assets |
4,424,994,830.61 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
147,488,893.73 |
| Long-term Equity Investment |
391,433,196.92 |
| Investment Properties |
-- |
| Fixed Assetes |
348,233,364.65 |
| Under-construction Projects |
357,344,594.34 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
272,726,278.30 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
53,897,412.31 |
| Deferred Income Tax Assets |
75,756,553.65 |
| Other Non-Current Assets |
4,535,334,011.29 |
| Sub-Total of Non-Current Assets |
7,084,155,585.37 |
| Total Assets |
11,509,150,415.98 |
| Short-Term Loans |
493,279,714.82 |
| Trading Financial liabilities |
-- |
| Notes Payable |
291,641,641.98 |
| Accounts Payable |
214,029,782.72 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
367,551,292.02 |
| Taxes Payable |
52,507,999.15 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
608,686,819.17 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
52,081,683.36 |
| Other Current Liabilities |
59,895,026.93 |
| Sub-Total of Current Liabilities |
3,199,282,023.83 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,576,135.63 |
| Other Non-Current Liabilities |
415,181,781.63 |
| Sub-Total of Non-Current Liabilities |
541,076,950.11 |
| Total Liabilities |
3,740,358,973.94 |
| Paid-In Capital(Or Share Stock) |
416,880,452.00 |
| Capital Surplus |
4,751,035,105.30 |
| Surplus Reserve |
207,856,624.00 |
| LESS:Treasury Stock |
131,011,456.64 |
| Undistributed Profits |
2,311,548,096.43 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,768,791,442.04 |
| Owner's Equity（Stockholder's Equity） |
7,768,791,442.04 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,509,150,415.98 |
